← Back to Search

Behavioural Intervention

QuitBot Program for Cancer Prevention

N/A

Waitlist Available

Led By Jonathan Bricker, PhD

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No prior use of SFT

Age 18 and older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3- and 6-months post-randomization

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to create a chatbot app called QuitBot and use text messaging to help Native American and Alaska Native individuals quit smoking. It will assess the effectiveness of two remote smoking cessation programs tailored for

Who is the study for?

This trial is for American Indians and Alaska Natives who are looking to quit smoking. It's designed to help them with personalized support through a smartphone app called QuitBot and text messaging programs.

What is being tested?

The study tests two remote smoking cessation methods: the QuitBot app and a text messaging program. Both aim to provide motivation, support in setting goals, tasks for quitting smoking, and maintaining a smoke-free life.

What are the potential side effects?

Since this trial involves behavioral interventions like using an app or receiving texts rather than medication, there may be minimal physical side effects. However, participants might experience stress or frustration during the quitting process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have never used SFT.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3- and 6-months post-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3- and 6-months post-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3- and 6-months post-randomization for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

30-day point prevalence abstinence (PPA)

Secondary study objectives

30-day PPA

Agreement on goals of treatment

Agreement on tasks of treatment

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (QuitBot chatbot)Experimental Treatment4 Interventions

Participants participate in the QuitBot program which involves chatbot messages over 42 days. Therapy description withheld to protect the integrity of the study.

Group II: Arm II (QuitBot texting)Active Control4 Interventions

Participants participate in the QuitBot program which involves text messages over 42 days. Therapy description withheld to protect the integrity of the study.

0 / 2Eligibility criteria met